Tobin W. Juvenal serves as the Chief Commercial Officer at Castle Biosciences, Inc., a role he has held since joining the company in 2019. With over two decades of experience in the life sciences and diagnostics industries, Juvenal has been instrumental in driving the commercial growth and strategic direction of Castle Biosciences. Prior to his current position, he held various leadership roles at renowned companies such as Genomic Health, where he served as Senior Vice President of Sales and Marketing, and Ventana Medical Systems, a member of the Roche Group, where he was Vice President of Global Marketing. Juvenal's career is marked by significant achievements in expanding market access and enhancing product adoption within the molecular diagnostics sector. At Genomic Health, he played a pivotal role in the successful commercialization of the Oncotype DX breast cancer test, which has become a standard of care for many patients. His strategic vision and leadership skills have been crucial in scaling Castle Biosciences' operations and increasing the reach of their innovative diagnostic tests. Under his guidance, the company has seen substantial growth in its dermatologic, urologic, and ophthalmic testing portfolios, positioning Castle Biosciences as a leader in personalized medicine. As Chief Commercial Officer, Juvenal oversees the company's sales, marketing, and market access functions, ensuring that Castle Biosciences' cutting-edge diagnostic solutions reach healthcare providers and patients efficiently. His role involves collaborating closely with the executive team to align commercial strategies with the company's overall mission of improving patient care through advanced diagnostics. Juvenal's dedication to advancing the field of precision medicine and his ability to navigate complex market dynamics make him a vital asset to Castle Biosciences as they continue to innovate and grow.